Details
- Close date
- Tuesday, 31 December 2025
- Academic background
- Health Sciences
- Host campus
- Dunedin
- Qualification
- Master's, PhD, Honours
- Department
- Pathology (Dunedin)
- Supervisor
- Dr Kunyu Li, Dr kevin ly, Professor Antony Braithwaite
Overview
New Zealand has one of the highest incidences of inflammatory bowel disease (IBD) in the world. Currently, IBD can only be managed but not cured. The exact aetiology and pathologic events that drive chronic inflammation in IBD are currently unknown.
In our previous study, we found that UC patients with progressive disease had a higher expression of Δ133p53 in the inflamed bowel. In this project, we intend to find out the correlation between Δ133TP53 expression and IBD progression towards CRC, using human samples.
IThis project is suitable for postgraduate students who have a solid background in immunology and gut inflammation. Students with research experience in ddPCR, tissue digestion, laboratory mouse handling, multi-colour flow cytometric analysis and histological analysis are desired.
Depending on the student’s performance and the availability of research funding, this project could potentially be continued for a PhD degree.
Previous experience in laboratory mouse handling is essential for a MSc and PhD degree.
Close date
This research opportunity closes on Tuesday 31 December 2024
Useful information
Similar research opportunities
- A phoenix from the ashes: Do dying cancer cells induce drug-tolerance in lung cancer?
- A role for untranslated p53 mRNA in drug resistance
- Characterisation of YB-1 interactions with the cytoskeleton using live cell imaging
- Characteristion of YB-1 interactions with the cytoskeleton using live cell imaging
- Comprehensive characterization of uncommon TP53 mutations in cancer